Programmed Cell Death-Ligand 1 : Beitrag der Zytologie zur zielgerichteten Therapie von Lungenkarzinomen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Lübeck, Universität zu Lübeck, Dissertation, 2020
- Keyword
-
Lungenkrebs
Tumor
Cytologie
Zelle
Therapie
- Event
-
Veröffentlichung
- (where)
-
Lübeck
- (who)
-
Zentrale Hochschulbibliothek Lübeck
- (when)
-
2021
- Creator
-
van der Linde, Lea Isabell Shari
- Contributor
-
Welker, Lutz
Schaaf, Bernhard
- URN
-
urn:nbn:de:gbv:841-20210205278
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van der Linde, Lea Isabell Shari
- Welker, Lutz
- Schaaf, Bernhard
- Zentrale Hochschulbibliothek Lübeck
Time of origin
- 2021
Other Objects (12)
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death-ligand 1 expression in rectal cancer
Status of programmed death-ligand 1 expression in sarcomas
Programmed death-ligand 1 expression in carcinoma of unknown primary
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
Prognostic value of soluble programmed death-1 and soluble programmed death ligand-1 in severe traumatic brain injury patients
Widespread Hypertrophic Lichen Planus following Programmed Cell Death Ligand 1 Blockade
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Author Correction: Prognostic value of soluble programmed death-1 and soluble programmed death ligand-1 in severe traumatic brain injury patients
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death-ligand 1 expression in rectal cancer
Status of programmed death-ligand 1 expression in sarcomas
Programmed death-ligand 1 expression in carcinoma of unknown primary
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
Prognostic value of soluble programmed death-1 and soluble programmed death ligand-1 in severe traumatic brain injury patients
Widespread Hypertrophic Lichen Planus following Programmed Cell Death Ligand 1 Blockade
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Author Correction: Prognostic value of soluble programmed death-1 and soluble programmed death ligand-1 in severe traumatic brain injury patients
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death-ligand 1 expression in rectal cancer
Status of programmed death-ligand 1 expression in sarcomas
Programmed death-ligand 1 expression in carcinoma of unknown primary
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
Prognostic value of soluble programmed death-1 and soluble programmed death ligand-1 in severe traumatic brain injury patients
Widespread Hypertrophic Lichen Planus following Programmed Cell Death Ligand 1 Blockade
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma